Effective Shared Care Agreement Toolkit Launched Online
New interactive toolkit supports healthcare professionals in local development of shared care agreements
A new online resource – designed to assist healthcare professionals in the local development of shared care agreements – has been developed by Medicines Management, Keele University.
The Effective Shared Care Agreement Toolkit outlines clinical and patient management responsibilities and suggests how they can be shared between the secondary care specialist and general practitioner / primary care prescriber. Acting as a flexible template, the Toolkit enables users to consider proposed content – key principles, monitoring requirements, dosage and administration, contraindications, interactions, etc., – and tailor it to their local circumstances and requirements. Local agreements can be created and edited by ‘dragging and dropping’ suggested content into a unique template document. Each template can then be saved online for further review or downloaded to the user’s own computer.
Professor Stephen Chapman, Professor of Prescribing Studies at Keele University said, “Effective shared care agreements have been used for some years now to ensure consistency of care as drugs move from secondary to primary care. They are however, time consuming and resource intensive to produce. Providing an electronic template simplifies the process. The first, in what we hope will be a series of templates, is for dronedarone – a good illustration of the support required to best manage the transfer of patient treatment from the secondary care sector to general practice.”
The dronedarone Toolkit is designed to support healthcare professionals in creating agreements aligned to locally agreed policy on the prescribing of dronedarone for atrial fibrillation.
The Toolkit is available at www.esca-keele.co.uk and the dronedarone template is available at www.esca-keele.co.uk/dronedarone.
The Effective Shared Care Agreement Toolkit is not a recommendation to prescribe dronedarone. The decision to prescribe dronedarone is the responsibility of the respective local healthcare organisation and the Toolkit should only be used after the local decision to prescribe dronedarone has been taken.
The development of the Dronedarone Effective Shared Care Agreement Toolkit was made possible by an unrestricted educational grant provided by sanofi aventis in the UK.
If you require a screenshot of the Toolkit please contact Simon Thomas at Keele University (email: email@example.com; tel: 01782 715458).